Cowen Begins Coverage on Green Thumb Industries (OTCMKTS:GTBIF)

Share on StockTwits

Cowen began coverage on shares of Green Thumb Industries (OTCMKTS:GTBIF) in a report issued on Friday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $18.50 price target on the stock.

GTBIF has been the topic of a number of other research reports. Piper Jaffray Companies assumed coverage on Green Thumb Industries in a research report on Monday, August 12th. They set an overweight rating and a $13.00 price target on the stock. Compass Point assumed coverage on Green Thumb Industries in a research report on Monday, June 10th. They set a buy rating on the stock. Five analysts have rated the stock with a buy rating, The company presently has a consensus rating of Buy and a consensus target price of $15.88.

Shares of GTBIF stock opened at $9.52 on Friday. The business’s 50 day moving average is $9.02 and its two-hundred day moving average is $11.78. Green Thumb Industries has a 12-month low of $7.37 and a 12-month high of $25.03.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures and sells various cannabis products in the United States. The company's cannabis products include flower, concentrates for dabbing and vaporizing, edibles, and topical. It owns and operates a chain of retail cannabis stores under the RISE name. The company markets its products through third party retailers.

Read More: Do You Need a Fiduciary?

Analyst Recommendations for Green Thumb Industries (OTCMKTS:GTBIF)

Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SOTHERLY HOTELS/SH SH  Upgraded by Zacks Investment Research to Hold
SOTHERLY HOTELS/SH SH Upgraded by Zacks Investment Research to Hold
Solaredge Technologies  Lowered to Hold at Zacks Investment Research
Solaredge Technologies Lowered to Hold at Zacks Investment Research
Resonant  Upgraded to “Hold” at Zacks Investment Research
Resonant Upgraded to “Hold” at Zacks Investment Research
Portola Pharmaceuticals  PT Lowered to $44.00
Portola Pharmaceuticals PT Lowered to $44.00
UltraNote Coin Reaches Market Cap of $13,486.00
UltraNote Coin Reaches Market Cap of $13,486.00
FS KKR Capital Corp  Receives $7.63 Consensus PT from Analysts
FS KKR Capital Corp Receives $7.63 Consensus PT from Analysts


© 2006-2019 Ticker Report